Scientific deep-dive
Time-Restricted Eating for Prediabetes: Glucose Effects
A 2026 meta-analysis found small falls in HbA1c and fasting glucose with time-restricted eating in prediabetes. Individual trials disagree, and the studies reviewed here do not show that the approach prevents type 2 diabetes.
Time-restricted eating appears to lower blood sugar in prediabetes, but only slightly. A 2026 Diabetologia meta-analysis of randomized trials found an HbA1c reduction of 0.09 percentage points (95% CI, −0.16 to −0.02) and a fasting glucose reduction of 0.14 mmol/l (−0.27 to −0.01) in the prediabetes subgroup [1]. Individual prediabetes trials are small and do not agree with one another, and no study reviewed here measured whether the approach delays type 2 diabetes.
What the Diabetologia meta-analysis found
The review pooled ten randomized trials with 599 adults who had prediabetes or type 2 diabetes [1]. Eating windows ran from 4 to 10 hours a day, trials averaged 4 months, and the comparison in each was a diet without a time restriction [1]. Prediabetes was defined as fasting glucose of 5.6 to 6.9 mmol/l or HbA1c of 5.7% to 6.4% [1]. The abstract does not say how many of the 599 participants had prediabetes.
| Group | HbA1c (percentage points, 95% CI) | Fasting glucose (mmol/l, 95% CI) |
|---|---|---|
| All participants | −0.30 (−0.63 to 0.02); not significant | −0.30 (−0.53 to −0.07) |
| Prediabetes | −0.09 (−0.16 to −0.02) | −0.14 (−0.27 to −0.01) |
| Type 2 diabetes | −0.43 (−0.92 to 0.07); not significant | −0.48 (−0.78 to −0.17) |
All figures in the table come from that abstract [1]. Across all participants, the authors rated the evidence moderate certainty and concluded that time-restricted eating reduces fasting glucose but not HbA1c [1]. Body weight fell 1.6 kg in the pooled analysis, and results for insulin sensitivity, beta cell function, and continuous glucose monitoring were inconclusive [1]. They flagged imprecision from wide confidence intervals in some trials, possibly because of small samples [1].
The funding is worth knowing. The review received no specific grant, though three authors worked at Steno Diabetes Center Copenhagen, partly funded by a Novo Nordisk Foundation grant, and one was employed by Novo Nordisk [1]. The authors state that the funders had no role in the review [1].
How big is a 0.09-point change?
The prediabetes range used in the review spans 0.7 HbA1c points, from 5.7% to 6.4% [1], so the pooled change is about one-eighth of that width. The fasting glucose change of 0.14 mmol/l converts to roughly 2.5 mg/dL [1]. These are group averages over a few months. For someone whose HbA1c sits near a cutoff, a shift this size could change the label on a lab report without saying much about long-term risk.
Individual prediabetes trials point in different directions
In the Danish RESET trial, an exploratory analysis of 46 people with prediabetes found no between-group difference in fasting glucose or HbA1c at 6 weeks or 3 months on a 10-hour window [2]. Nighttime glucose was 0.3 mmol/L lower at 6 weeks (−0.6 to −0.1), but the effect was not maintained at 3 months [2].
TRIM is the most useful test of whether timing works apart from calories. Researchers fed 41 adults with obesity and prediabetes or diet-controlled diabetes the same calories and nutrients, either in a 10-hour window with 80% of calories before 1 p.m. or on a usual pattern with at least half of calories after 5 p.m. [3]. Weight fell 2.3 kg and 2.6 kg respectively, and glycemic measures did not differ [3]. The study was small, with baseline weight differences, and participants were 93% women and 93% Black [3]. A later analysis of 39 TRIM participants found no between-group differences in eating behavior, appetite hormones, or inflammatory markers [4].
Two tightly controlled crossover studies are more encouraging. In the first, men with prediabetes were fed enough to hold their weight on a 6-hour early schedule, with dinner before 3 p.m., and showed better insulin sensitivity, beta cell responsiveness, and blood pressure compared with a 12-hour schedule [5]. In the second, 10 adults with prediabetes spent one week on each schedule; early eating reduced glycemic variation and time spent above 140 mg/dL [6]. Both are short, and the authors of the first called it a proof-of-concept study [5].
The free-living data are less tidy. A Thai trial of 72 adults with impaired fasting glucose found no significant differences in glucose, HbA1c, or weight among time-restricted eating with behavioral support, time-restricted eating alone, and usual care [7]. Lower glucose appeared only when the analysis was limited to people who could follow the protocol [7], and a comparison restricted that way can be biased because adherent people may differ in other ways. In a separate 14-week weight-loss trial, a prediabetes subgroup on a 7 a.m. to 3 p.m. schedule had an HbA1c 0.3% ± 0.1% lower than controls (P = 0.04), a finding the authors described as exploratory [8].
Does eating earlier matter?
Early schedules produced the positive results above [5][6][8], which makes morning-weighted eating an attractive hypothesis. TRIM complicates it, because that trial also concentrated calories before 1 p.m. and still found no glycemic difference [3]. The Diabetologia abstract does not report a comparison of early and late windows [1], so the data read here cannot name a best schedule.
Weight, calories, and other forms of fasting
Whether the glucose change depends on weight loss remains unsettled. The TRIM authors suggested that weight effects seen in earlier time-restricted eating studies may be due to eating fewer calories [3]. That matches the broader finding in our review of intermittent fasting for weight loss, while the feeding study in men suggests some metabolic effects can occur without weight loss [5].
A 2024 meta-analysis of intermittent fasting, which mixed several fasting patterns and combined prediabetes with type 2 diabetes, tells a similar story. Across 14 studies it found lower HbA1c (−0.81%) and fasting glucose (−0.36 mmol/L) against a control diet, but no HbA1c or lipid advantage against calorie restriction [10]. It does not isolate time-restricted eating in prediabetes. For someone who finds a clock easier than counting calories, those findings suggest similar glycemic results, not stronger ones.
How it compares with proven diabetes prevention
The strongest prevention evidence measures a different and more important outcome: whether people develop diabetes. In the Diabetes Prevention Program, a lifestyle program aiming for at least 7% weight loss and 150 minutes of weekly activity reduced diabetes incidence by 58% over an average of 2.8 years, and metformin reduced it by 31%, compared with placebo [12]. In STEP 10, semaglutide 2.4 mg returned 81% of adults with obesity and prediabetes to normal glucose at week 52, against 14% on placebo, in an intention-to-treat analysis of a Novo Nordisk funded trial [13]. That endpoint is a return to normal glucose at one year, not new cases of diabetes, so STEP 10 is also lab evidence rather than a test of prevention [13]. Our review of semaglutide for prediabetes covers the regulatory side.
These are not head-to-head comparisons. The populations, durations, and endpoints differ, and STEP 10 enrolled people with a mean BMI of 40.1 [13]. The contrast with the Diabetes Prevention Program is in the kind of evidence: time-restricted eating trials in prediabetes report short-term lab changes, averaging 4 months in the Diabetologia review [1], and that review’s authors call for large, long-term studies on prevention [1].
Can people stick with it, and what about safety?
A 12-week pilot in 34 older adults with prediabetes and obesity paired a self-selected 8-hour window with aerobic or resistance training [9]. Participants kept to the window about 75% of the time, or 5.8 days a week, and 73% and 80% of the two groups finished [9]. The trial had no group without time-restricted eating, so it speaks to feasibility and not to benefit.
A 2026 Personal View in Lancet Diabetes & Endocrinology, whose lead author wrote an intermittent-fasting diet book, notes that intermittent fasting is not yet recommended in the American Diabetes Association Standards of Care, and argues it should be added as a lifestyle option for type 2 diabetes [11]. For prediabetes its language is more guarded: fasting “might also reduce glycaemia” [11]. Its authors also report no increased hypoglycemia risk in type 2 diabetes when medications are adjusted using simple rules [11], and that condition matters.
What to raise with a prescriber
Ask before changing meal timing if you take a glucose-lowering medication, because doses may need adjusting. It is also worth mentioning pregnancy, any history of an eating disorder, or a schedule that makes long gaps between meals hard to manage. If you are on a GLP-1, see our review of combining a GLP-1 with intermittent fasting, and ask how to meet your protein needs inside a shorter window.
For now, a reader with prediabetes can reasonably treat time-restricted eating as one way to structure a diet, with a small average effect on glucose and no diabetes-prevention data behind it. A repeat HbA1c and fasting glucose, ordered by a clinician, is the way to see whether it is doing anything for you.
Frequently Asked Questions
References
- 1.Viple F, Pedersen SS, Andersen TH, Raben A, Termannsen AD, Salling J. Effects of time-restricted eating on markers of glucose metabolism and regulation in individuals with prediabetes or type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Diabetologia. 2026. PMID: 42507108.
- 2.Kloura C, Jensen MM, Ekblond TS, Pedersen HE, Raben A, Clemmensen KKB, et al. Effects of time-restricted eating on glycemic control and variability in individuals with overweight/obesity and prediabetes: A secondary analysis of the RESET randomized controlled trial. Diabetes Res Clin Pract. 2026. PMID: 42025926.
- 3.Maruthur NM, Pilla SJ, White K, Wu B, Maw MTT, Duan D, et al. Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity: A Randomized Controlled Trial. Ann Intern Med. 2024. PMID: 38639542.
- 4.Duan D, Carnell S, Pilla SJ, Chung ST, Clark JM, Maruthur NM. Time-Restricted Eating on Appetite and Inflammation in Adults With Obesity and Prediabetes: A Randomized Feeding Study. Obesity (Silver Spring). 2026. PMID: 42508996.
- 5.Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018. PMID: 29754952.
- 6.Bruno J, Walker JM, Nasserifar S, Upadhyay D, Ronning A, Vanegas SM, et al. Weight-neutral early time-restricted eating improves glycemic variation and time in range without changes in inflammatory markers. iScience. 2024. PMID: 39759025.
- 7.Suthutvoravut U, Anothaisintawee T, Boonmanunt S, Pramyothin S, Siriyothin S, Attia J, et al. Efficacy of Time-Restricted Eating and Behavioral Economic Intervention in Reducing Fasting Plasma Glucose, HbA1c, and Cardiometabolic Risk Factors in Patients with Impaired Fasting Glucose: A Randomized Controlled Trial. Nutrients. 2023. PMID: 37836517.
- 8.Rehman Z, Altonji OM, Steger FL, Jamshed H, Richman JS, Warriner AH, et al. Do the Effects of Early Time-Restricted Eating Vary by Cardiometabolic Phenotype, Age, Sex, or Race? A Secondary Analysis of a Randomized Controlled Trial. J Nutr. 2026. PMID: 41941962.
- 9.Sanchez Perez J, Czyzewski O, Hamm A, Fought-Boudaia A, Cares K, Motl RW, et al. Feasibility and acceptability of 8-h time-restricted eating combined with aerobic or resistance training in older adults with prediabetes and obesity. Ann Behav Med. 2026. PMID: 42847405.
- 10.Khalafi M, Habibi Maleki A, Symonds ME, Rosenkranz SK, Rohani H, Ehsanifar M. The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2024. PMID: 38956175.
- 11.Varady KA, Chow LS, Peterson CM. Intermittent fasting to treat diabetes: time to update clinical practice guidelines. Lancet Diabetes Endocrinol. 2026. PMID: 42361830.
- 12.Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002. PMID: 11832527.
- 13.McGowan BM, Bruun JM, Capehorn M, Pedersen SD, Pietiläinen KH, Muniraju HAK, et al. Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial. Lancet Diabetes Endocrinol. 2024. PMID: 39089293.
Related research
16:8 vs 5:2 Fasting: Which Works Better for Weight Loss?
Only one randomized trial has been found comparing 16:8 and 5:2 directly, and it lasted 4 weeks. Longer trials suggest both land near ordinary calorie restriction, so fit and adherence may matter more than the schedule.
8 min read
Time-Restricted Eating With Lifting: Fat Loss or Muscle Loss?
Short trials suggest time-restricted eating alongside resistance training may trim a little fat without clear muscle loss. Here is what new meta-analyses show, why calories and protein may explain much of it, and where the evidence stops.
8 min read
Frozen Shoulder and Diabetes: Risk, Weight and GLP-1 Evidence
Diabetes raises the odds of frozen shoulder (adhesive capsulitis) several times over, and prediabetes adds a smaller risk. What the evidence says about blood sugar, BMI, GLP-1 drugs and the treatment with the best support.
10 min read
GLP-1 + Metformin: Stacking for Weight Loss — The Real Math
Metformin produces about 2 kg of weight loss in adults with prediabetes over 2-3 years (DPP). GLP-1 drugs produce 15-21% at 68-72 weeks. The combination is additive but modestly so. We review the DPP, the SUSTAIN-7 metformin background, and the GI side-effect synergy.
11 min read
GLP-1, Fasting Insulin & HOMA-IR: Insulin Resistance
Fasting insulin and HOMA-IR — the everyday markers of insulin resistance — generally improve on a GLP-1. Semaglutide lowered both in STEP 1. We cover what the numbers mean, the weight-loss driver, and HOMA-IR's limits (it's not valid on insulin).
7 min read
Dupuytren's Contracture, Diabetes and Weight: What the Evidence Shows
Dupuytren's contracture is about three times more likely with diabetes, and high blood sugar looks causal, but higher BMI is linked to lower risk. What the evidence says about weight loss, alcohol, needle, collagenase and surgical treatment, and the missing GLP-1 data.
10 min read
Where to get GLP-1 safely: vetted online providers
Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
CoreAge Rx
Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Read full review →Pricing Compare
Get started →Pricing Compare
Get started →Gala
Compounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping
Read full review →Pricing Compare
Get started →